Asthma and other recurrent wheezing disorders in children (chronic)

Stephen William Turner1, Amanda Jane Friend, Augusta Okpapi

  • 1University of Aberdeen, Aberdeen, UK.

BMJ Clinical Evidence
|February 7, 2012
PubMed

Insights

This review examines treatments for childhood asthma, focusing on inhaled beta(2) agonists and additional therapies for uncontrolled cases. It evaluates the effectiveness and safety of various asthma medications.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Childhood asthma is a prevalent chronic respiratory condition with no cure, but manageable symptoms.
  • Risk factors include atopy, frequent wheezing, airway obstruction, and bronchial hyperresponsiveness.
  • Triggers for asthma exacerbations encompass infections, allergens, smoke exposure, and exercise.

Purpose of the Study:

  • To assess the impact of single-agent prophylaxis in children using as-needed inhaled beta(2) agonists for asthma.
  • To evaluate additional prophylactic treatments for childhood asthma not adequately controlled by standard inhaled corticosteroids.

Main Methods:

  • A systematic review was conducted, searching major databases up to June 2010.
  • Included studies comprised systematic reviews, randomized controlled trials (RCTs), and observational studies.
  • Harms alerts from regulatory agencies like the FDA and MHRA were also incorporated.

Main Results:

  • Forty-eight studies met the inclusion criteria for the review.
  • A GRADE evaluation assessed the quality of evidence for various interventions.
  • Information on the effectiveness and safety of multiple asthma interventions was compiled.

Conclusions:

  • The review presents data on long-acting beta(2) agonists, inhaled corticosteroids (standard and higher doses), oral leukotriene receptor antagonists, omalizumab, and oral theophylline.
  • Effectiveness and safety profiles of these interventions were analyzed.
  • Findings inform treatment decisions for childhood asthma management.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: